Product Information
RISEDRONATE SOD DR 35 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $29.8417 per EA under NDC 59762040704. Its NADAC has been published 438 times since Apr 4, 2018.
FDA first approved this application on Oct 8, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30.1; 4.9 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762040704
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RISEDRONATE SODIUM HEMIPENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022560FDA Approved
10/8/2010
TE Code
AB
On Market Since
3/2/2018
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SOD DR 35 MG TAB has been published 438 times since Apr 4, 2018, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29.8417 per EA |
|---|---|
| All-time high | $37.4668 (Jan 15, 2020) |
| All-time low | $20.7485 (Nov 20, 2024) |
| 52-week high | $29.8417 |
| 52-week low | $23.8876 |
| Median price | $27.7950 |
| Average price | $28.7215 |
| Largest weekly change | +44.9% (Aug 19, 2020) |
| Weeks tracked | 438 |
| Tracking since | Apr 4, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RISEDRONATE SOD DR 35 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SOD DR 35 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $29.8417 per EA (NDC 59762040704), effective Aug 19, 2026.
How has the price of RISEDRONATE SOD DR 35 MG TAB changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SOD DR 35 MG TAB has declined 10.5%. It has been tracked across 438 weekly CMS publications since Apr 4, 2018.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SOD DR 35 MG TAB?
Since Apr 4, 2018, the NADAC for RISEDRONATE SOD DR 35 MG TAB has ranged from a low of $20.7485 (Nov 20, 2024) to a high of $37.4668 (Jan 15, 2020), with a median of $27.7950 per EA.
Are there cheaper alternatives to RISEDRONATE SOD DR 35 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RISEDRONATE SOD DR 35 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures RISEDRONATE SOD DR 35 MG TAB?
RISEDRONATE SOD DR 35 MG TAB (NDC 59762040704) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.